首頁 > 市場調查報告書 > 醫療設備

感染疾病

市場調查報告書

商品編碼

2030255

感染控制服飾市場－全球產業規模、佔有率、趨勢、機會與預測：按產品、最終用途、地區和競爭格局分類，2021-2031年

Infection Control Apparel Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End Use, By Region & Competition, 2021-2031F

出版日期: 2026年05月01日 | 出版商:

TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球感染預防服飾市場預計將從 2025 年的 184.3 億美元成長到 2031 年的 241.7 億美元，複合年成長率為 4.62%。

這些專業防護衣在各種醫療環境中發揮至關重要的防護作用，最大限度地減少有害微生物在患者、醫護人員及其周圍環境中的傳播。推動該市場發展的關鍵因素包括醫療相關感染的增加、國際上對防護工具的監管日益嚴格、醫護人員職業安全意識的提高以及全球醫療基礎設施的持續發展。

市場概覽
預測期	2027-2031
市場規模：2025年	184.3億美元
市場規模：2031年	241.7億美元
複合年成長率：2026-2031年	4.62%
成長最快的細分市場	罩衣
最大的市場	北美洲

然而，高品質防護衣所需先進材料成本的不斷上漲，正成為市場成長的一大障礙。歐洲一次性用品和不織布協會 (EDNA) 的一份報告強調了這一問題，報告指出，作為感染預防服裝關鍵材料的不織布，其歐洲產量到 2025 年將下降約 2.2%，至 291.9 萬噸。

市場促進因素

全球感染預防服飾市場的主要驅動力是感染疾病和醫療相關感染（HAI）的增加。醫療機構需要強力的防護措施來防止這些病原體的傳播，從而推動了對專用服飾的需求。歐洲疾病預防控制中心（ECDC）於2025年5月發布的一份關於HAI和抗生素使用情況的報告也印證了這一點，該報告指出，2023年至2024年間，歐洲長期護理機構中超過3%的居民至少感染過一種HAI。這些感染疾病的持續風險凸顯了防護衣在保障醫護人員和病人安全方面的重要性。

此外，嚴格的醫療法規和指南強制要求使用指定的防護工具，這也加速了市場成長。這些法規要求醫療機構遵守特定的感染預防規程，從而維持了對受監管防護衣的穩定需求。例如，2025年5月，歐盟委員會第2025/895號實施決定修訂了個人防護設備（PPE）的協調標準，要求製造商在2026年11月16日之前達到更新後的EN標準。這些監管變化迫使企業推動創新並確保合規，從而促進了市場的整體強勁表現。特別是，行業領導者美敦力（Medline）在2025年實現了284億美元的全年淨銷售額，年增11.5%。

市場挑戰

全球感染預防服飾市場擴張的一大障礙是高性能防護衣生產所需先進材料價格飆升。隨著這些專用服裝原料成本的增加，這些必需品的總生產成本自然也隨之上升。製造成本的增加直接導致醫院、診所等醫療機構的採購價格上漲。因此，預算緊張的醫療機構可能難以採購到足夠的高階防護衣，被迫推遲必要的升級改造，或選擇價格更低、品質更差的替代品。

這些經濟壓力可能會減緩即使是已被證明能有效阻止病原體傳播的最佳防護方案的廣泛應用。美國全國製造商協會 (NAM) 發布的《2025 年第一季製造業展望調查》也印證了這一趨勢，該調查預測明年原料和投入成本將上漲 5.5%。原物料價格的持續上漲迫使製造商在接受更低的利潤率或提高售價之間做出選擇，這造成了財務障礙，限制了整體市場成長，並使得向醫護人員提供優質防護工具變得更加困難。

市場趨勢

智慧布料和穿戴式技術的進步正在顯著改變感染預防服裝市場，催生出強大的服裝。這些創新技術超越了傳統的被動防護屏障，採用能夠主動回應環境、檢測病原體並即時監測生理徵兆的纖維。透過整合微電子元件和感測器，這種智慧服裝可為醫療保健使用者提供持續的健康狀況和暴露數據。醫療產業的材料創新也推動了這一趨勢。例如，根據 WHBL 2026 年 2 月 10 日報，杜邦醫療和水技術部門的淨銷售額成長了 4%，達到 8.21 億美元。這主要得益於醫療設備和包裝材料需求的成長，顯示市場對能夠提升病患和醫護人員情境察覺的先進材料接受度很高。

另一個改變感染控制服飾市場的關鍵趨勢是可重複使用且環保的防護工具（ PPE）的發展。這項轉變的驅動力來自日益增強的環保意識、減少一次性PPE廢棄物的迫切需求以及醫療機構降低營運成本的要求。採用耐用、優質布料製成的可重複使用服裝能夠經受多次嚴格的消毒和洗滌流程，而不會影響其防護性能，使其成為一次性產品的理想替代品。 MedClean發佈的題為《加速醫療機構採用可重複使用個人防護工具（PPE）》的2026年白皮書也印證了這一點。白皮書指出，採用可重複使用罩衣的醫院與使用一次性產品相比，成本降低了52%。這種經濟效益與環境優勢相結合，正在加速向可重複使用防護衣的轉變。

The Global Infection Control Apparel Market is projected to grow from USD 18.43 Billion in 2025 to USD 24.17 Billion by 2031 at a 4.62% CAGR. These specialized protective garments act as essential barriers in various healthcare environments to minimize the spread of harmful microorganisms among patients, medical staff, and their surroundings. Key factors propelling this market include the rising rate of healthcare-associated infections, stricter international regulations for protective gear, growing occupational safety awareness among medical professionals, and the ongoing development of global healthcare infrastructure.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 18.43 Billion
Market Size 2031	USD 24.17 Billion
CAGR 2026-2031	4.62%
Fastest Growing Segment	Isolation Gowns
Largest Market	North America

However, market growth faces a major hurdle due to the increasing expenses associated with advanced materials needed for high-quality protective clothing. Highlighting this issue, the European Disposables and Nonwovens Association reported that European production of nonwovens-a crucial material for infection control garments-fell by roughly 2.2% in 2025 to reach 2,919,000 tons.

Market Driver

The Global infection control apparel market is primarily fueled by the growing prevalence of infectious diseases and healthcare-associated infections (HAIs). The need to halt the spread of these pathogens in medical settings requires strong protective protocols, driving up the need for specialized clothing. Illustrating this point, a May 2025 report from the European Centre for Disease Prevention and Control on HAIs and antimicrobial use found that over 3% of European long-term care residents contracted at least one HAI during 2023 or 2024. The persistent danger of these infections highlights how vital protective garments are for ensuring the safety of both healthcare workers and patients.

Market growth is additionally accelerated by strict healthcare regulations and guidelines that require the adoption of designated protective gear. By forcing healthcare institutions to follow specific infection prevention protocols, these rules maintain a steady demand for regulatory-compliant apparel. For instance, in May 2025, the European Commission's Implementing Decision 2025/895 revised the harmonized standards for personal protective equipment, mandating that manufacturers meet updated EN norms by November 16, 2026. These regulatory shifts compel companies to innovate and ensure compliance, contributing to strong overall market performance; notably, leading industry firm Medline achieved $28.4 billion in full-year net sales for 2025, representing an 11.5% year-over-year increase.

Market Challenge

A major obstacle to the expansion of the global infection control apparel market is the escalating price of advanced materials required to manufacture high-performance protective clothing. As the raw materials for these specialized garments grow more costly, the overall production expenses for these essential items naturally increase. These elevated manufacturing costs lead directly to higher purchasing prices for medical facilities, such as hospitals and clinics. As a result, healthcare institutions facing tight budgets might struggle to purchase adequate supplies of top-tier protective gear, which could force them to postpone necessary upgrades or opt for cheaper, lower-quality alternatives.

These economic strains can slow down the broad implementation of the best protective solutions, even though they are proven to stop the spread of pathogens effectively. Highlighting this trend, the Q1 2025 Manufacturers' Outlook Survey by the National Association of Manufacturers projected a 5.5% increase in raw material and input costs over the following year. This continuous rise in material prices forces manufacturers to either accept narrower profit margins or raise their selling prices, erecting a financial hurdle that restricts broader market growth and complicates the task of providing healthcare workers with superior protective equipment.

Market Trends

The infection control apparel market is being heavily shaped by progress in smart fabric technologies and wearable tech, leading to clothing with advanced capabilities. Going beyond traditional passive barriers, these breakthroughs feature textiles that can actively respond to the environment, detect pathogens, and monitor physiological signs in real time. By embedding microelectronics and sensors, this smart clothing supplies continuous health and exposure data for users in medical settings. This movement is backed by broader material innovations in the healthcare industry; for instance, WHBL reported on February 10, 2026, that DuPont saw a 4% increase in its healthcare and water technologies net sales, reaching $821 million due to higher demand for medical devices and packaging, signaling strong market readiness for advanced materials that improve situational awareness for both patients and medical staff.

Another vital trend transforming the infection control apparel market is the creation of reusable and eco-friendly protective gear. This transition is motivated by a growing awareness of environmental issues, the urgent need to cut down on waste from single-use personal protective equipment, and healthcare providers' desire to lower operational costs. Made from resilient, top-tier fabrics, reusable clothing can endure multiple intense sterilization and washing routines without losing its defensive qualities, presenting an attractive substitute for disposable alternatives. Demonstrating this, a 2026 whitepaper by MedClean titled "Advancing the Adoption of Reusable Personal Protective Equipment (PPE) in Healthcare" noted that hospitals using reusable isolation gowns achieved a 52% cost saving over single-use items, a financial upside that, along with the ecological benefits, is speeding up the transition to reusable apparel.

Key Market Players

3M Company
DuPont de Nemours, Inc.
Cardinal Health, Inc.
Owens & Minor, Inc.
Medline Industries, Inc.
Lindstrom Group
Ansell Ltd
Delta Plus Group
Lakeland Industries Inc.
Protective Industrial Products, Inc.

Report Scope

In this report, the Global Infection Control Apparel Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Infection Control Apparel Market, By Product

Isolation Gowns
Chemotherapy Gowns
Lab Coats
Jackets

Infection Control Apparel Market, By End Use

Hospitals
Ambulatory & Surgical Centers
Clinics
Research & Diagnostic Labs
Others

Infection Control Apparel Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Infection Control Apparel Market.

Available Customizations:

Global Infection Control Apparel Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Infection Control Apparel Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Isolation Gowns, Chemotherapy Gowns, Lab Coats, Jackets)
- 5.2.2. By End Use (Hospitals, Ambulatory & Surgical Centers, Clinics, Research & Diagnostic Labs, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2025)
5.3. Market Map

6. North America Infection Control Apparel Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By End Use
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Infection Control Apparel Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By End Use
- 6.3.2. Canada Infection Control Apparel Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By End Use
- 6.3.3. Mexico Infection Control Apparel Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By End Use

7. Europe Infection Control Apparel Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By End Use
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Infection Control Apparel Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By End Use
- 7.3.2. France Infection Control Apparel Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By End Use
- 7.3.3. United Kingdom Infection Control Apparel Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By End Use
- 7.3.4. Italy Infection Control Apparel Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By End Use
- 7.3.5. Spain Infection Control Apparel Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By End Use

8. Asia Pacific Infection Control Apparel Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By End Use
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Infection Control Apparel Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By End Use
- 8.3.2. India Infection Control Apparel Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By End Use
- 8.3.3. Japan Infection Control Apparel Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By End Use
- 8.3.4. South Korea Infection Control Apparel Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By End Use
- 8.3.5. Australia Infection Control Apparel Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By End Use

9. Middle East & Africa Infection Control Apparel Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By End Use
- 9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Infection Control Apparel Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By End Use
- 9.3.2. UAE Infection Control Apparel Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By End Use
- 9.3.3. South Africa Infection Control Apparel Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By End Use

10. South America Infection Control Apparel Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By End Use
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Infection Control Apparel Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By End Use
- 10.3.2. Colombia Infection Control Apparel Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By End Use
- 10.3.3. Argentina Infection Control Apparel Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By End Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Infection Control Apparel Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. 3M Company
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. DuPont de Nemours, Inc.
15.3. Cardinal Health, Inc.
15.4. Owens & Minor, Inc.
15.5. Medline Industries, Inc.
15.6. Lindstrom Group
15.7. Ansell Ltd
15.8. Delta Plus Group
15.9. Lakeland Industries Inc.
15.10. Protective Industrial Products, Inc.